Now that the Trump administration has imposed 25% tariffs on items from Canada, the Canadian authorities is levying tariffs in return. However different measures are additionally being examined and one notion the Canadian authorities ought to take into account is suspending patent rights held by U.S. firms, together with pharmaceutical firms, based on Richard Gold, a professor of regulation and medication at McGill College who focuses on mental property points.
As he sees it, the pharmaceutical trade would have so much to lose ought to the Canadian authorities take such a step and, subsequently, would really feel compelled to foyer the White Home to roll again the tariffs. After all, there are a whole lot of variables concerned in such calculations. We spoke with Gold about this concept, which he floated a number of weeks in the past in Canada, and what it could take to occur. That is an edited model of our dialog.
So the place does this proposal come from?
This text is unique to STAT+ subscribers
Unlock this text — plus in-depth evaluation, newsletters, premium occasions, and information alerts.
Have already got an account? Log in
To learn the remainder of this story subscribe to STAT+.
